“Volume 11” folder 7 of 9: Departmental Procedures , 1973 - 1974

• Note: the “See also” lists are for carbon copies of the memos, minus any referenced attachments • Presumed photocopy of memo on Marion Laboratories letterhead dated September 12, 1973; re: “Twenty Points: Guidelines for Constructing Experimental Protocols” o See also folder 24 • Presumed photocopy of memo on Marion Laboratories letterhead dated September 12, 1973; re: “Fifteen Points: Guidelines for Writing Reports of Clinical Investigations” o See also folder 24 • Presumed photocopy of memo on Marion Laboratories letterhead dated September 20, 1973; re: “Abbreviations” o See also folder 24 • Presumed photocopy of memo on Marion Laboratories letterhead dated September 20, 1973; re: “Uniformity in Departmental Typographic Style” o See also folder 24 • Presumed photocopy of memo on Marion Laboratories letterhead dated January 16, 1974; re: “Parking at FDA” o See also folder 25 • Presumed photocopy of memo on Marion Laboratories letterhead dated September 20, 1973; re: “Typographic and Taxonomic Vignettes” o See also folder 25 • Presumed photocopy of memo dated July 17, 1974; re: “Trademark Protection” o See also folder 27 • Presumed photocopy of memo on Marion Laboratories letterhead dated February 18, 1974; re: “R&D Capital Expenditure Requests—Purchase Order Coding Requirements” • Presumed photocopy of memo on Marion Laboratories letterhead dated December 16, 1974; re: “Information Requirements for Approval of R&D Capital Expenditure” • Presumed Photocopy of dated September 7, 1973; re: “Clinical Case Reports: Routing” o See also folder 24 • Presumed photocopy of memo on Marion Laboratories letterhead dated October 1, 1973; re: “Keying Letters and Memos” o See also folder 24 • Presumed photocopy of memo on Marion Laboratories letterhead dated November 23, 1973; re: “Communication Copies” o See also folder 24 • Presumed photocopy of memo dated November 27, 1973; re: “Communications for or to Marion Divisions/Subsidiaries” o See also folder 24 • Presumed photocopy of memo on Marion Laboratories letterhead dated March 28, 1974; re: “Auto Mileage/Gasoline Specifications” o See also folder 25 • Presumed photocopy of memo on Marion Laboratories letterhead dated March 28, 1974; re: “INDs and NDAs: Handling Reports and Raw Date Between Corporate Medical and Regulatory Departments” o See also folder 25 • Presumed photocopy of memo on Marion Laboratories letterhead dated April 1, 1974; re: “Labels for Clinical Trial Supplies (CTS): Policy and Procedure” o See also folder 26 • Presumed photocopy of memo on Marion Laboratories letterhead dated May 6, 1974; re: “Confidential In-House Communications” o See also folder 26 • Presumed photocopy of a carbon copy of a memo dated May 7, 1974; re: “Drug Supplies for Animal or In Vitro Research” o See also folder 26 • Presumed photocopy of memo on Marion Laboratories letterhead dated June 26, 1974; re: “Editorial and Typographic Vignettes” o See also folder 26 • Presumed photocopy of memo on Marion Laboratories letterhead dated August 16, 1974; re: Putting our Best Foot Forward” o See also folder 27 • Presumed photocopy of memo on Marion Laboratories letterhead dated August 16, 1974; re: “Monitor’s Daily Log and Monitor’s Monthly Report” o See also folder 27 • Presumed photocopy of memo on Marion Laboratories letterhead dated August 26, 1974; re: “Distribution of Clinical Research Reports” o See also folder 27 • Presumed photocopy of memo on Marion Laboratories letterhead dated September 4, 1974; re: “Travel Procedures” o See also folder 27 • Presumed photocopy of memo on Marion Laboratories letterhead dated September 24, 1974; re: “Xeroxing: Recording Departmental Codes” o See also folder 27 • Presumed photocopy of memo on Marion Laboratories letterhead dated September 27, 1974; re: “R&D Projects Monthly Status Report” • Presumed photocopy of memo on Marion Laboratories letterhead dated October 4, 1974; re: “R&D Interdepartmental Requests” • Presumed photocopy of memo on Marion Laboratories letterhead dated January 8, 1975; re: “R&D Project Committee”